Securities code: Andon Health Co.Ltd(002432) securities abbreviation: Andon Health Co.Ltd(002432) Announcement No.: 2022056 Andon Health Co.Ltd(002432)
On the repurchase upon maturity of repurchase securities trading agreed by the controlling shareholders
And the announcement that the shareholding ratio changes by more than 1%
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and bear joint and several liabilities for false records, misleading statements or major omissions in the announcement Andon Health Co.Ltd(002432) (hereinafter referred to as “the company”) was established on May 20, 2022
We received a notice from the controlling shareholder Shihezi Sanhe equity investment partnership (limited partnership) (hereinafter referred to as “Sanhe investment”), and learned that it has handled the due repurchase procedures of agreed repurchase securities transactions with the securities company. The details are as follows:
1、 Agreed repurchase securities transactions handled in the early stage
On May 18, 2021, Sanhe investment and Shanxi Securities Co.Ltd(002500) (hereinafter referred to as “Shanxi certificate”)
Securities “) has conducted agreed repurchase securities transactions. See the company’s disclosure on May 20, 2021 for details
Announcement on the agreed repurchase securities trading by controlling shareholders and the change of shareholding ratio exceeding 1% (Announcement No.: 2021035).
2、 Maturity repurchase of agreed repurchase securities transactions 1. Basic information
Information disclosure obligor Shihezi Sanhe equity investment partnership (limited partnership)
Address: room 5-19, No. 37, Beisi East Road, Shihezi Development Zone, Xinjiang
Change time of Equity: May 19, 2022
Stock brief Andon Health Co.Ltd(002432) stock code Andon Health Co.Ltd(002432)
Called change class
Type (can increase more ■ decrease □ concerted action □ yes □ no ■
(optional)
Whether it is the largest shareholder or actual controller yes ■ no □
2. Changes in equity this time
Type of shares (A shares, B shares, etc.) number of shares increased / decreased (10000 shares) proportion of increased / decreased shares (%)
A shares 950 1.97%
Total 950 1.97%
The way of equity change this time (centralized trading through the stock exchange □
Multiple choice) block trading through stock exchange □
Others ■ (agreed repurchase securities trading)
Self owned funds ■ bank loans □ funds for this share increase borrowed from other financial institutions □ shareholder investment funds □ source (multiple choices) others □ (please specify)
Not involving the source of funds □
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Nature of shares: number of shares (10000 shares in total share capital) (10000 shares in total share capital) cases (%) (%)
Total shares held 1094979 22.74% 1189979 24.72%
Including: shares with unlimited sales conditions 1094979 22.74% 1189979 24.72%
Shares with limited sales conditions 0
4. Implementation of commitments, plans, etc
Whether this change is performed yes □ no ■
If yes, please explain the specific conditions of the commitment, intention, plan and implementation progress. Whether there is any violation of the securities law in this change
Municipal company acquisition management office yes □ no ■
If yes, please explain the specific situation, rectification plan and treatment measures of violations. Regulations, departmental rules, normative documents and the business rules of the exchange. 5. The shares with restricted voting rights shall be subject to Article 6 of the securities law
Provisions of Article 13, yes □ no ■
If yes, please specify the proportion of corresponding shares in the share capital of the existing listed company. ■
2. Relevant written commitment documents □
3. Written opinions of lawyers □
4. Other documents required by SZSE ■
3、 Other information
1. This repurchase transaction is performed by Sanhe investment in accordance with the relevant agreements of the agreed repurchase securities transaction
Repurchase obligation: after the completion of this repurchase transaction, there is no agreed repurchase securities transaction of Sanhe investment;
2. This repurchase transaction does not violate the provisions of relevant laws, regulations and business rules, such as the measures for the administration of the acquisition of listed companies, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, and the measures for agreed repurchase securities trading, registration and settlement business;
3. This equity change will not lead to the change of the controlling shareholder and actual controller of the company, will not damage the interests of the company and other shareholders, and will not have an impact on the corporate governance structure and sustainable operation.
It is hereby announced.
Andon Health Co.Ltd(002432) board of directors
May 21, 2022
